0001209191-17-001599.txt : 20170104 0001209191-17-001599.hdr.sgml : 20170104 20170104202207 ACCESSION NUMBER: 0001209191-17-001599 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170103 FILED AS OF DATE: 20170104 DATE AS OF CHANGE: 20170104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ProNAi Therapeutics Inc CENTRAL INDEX KEY: 0001290149 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ? 885 WEST GEORGIA STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 BUSINESS PHONE: 604-558-6536 MAIL ADDRESS: STREET 1: 2150 ? 885 WEST GEORGIA STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kowalski Mark CENTRAL INDEX KEY: 0001628357 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37490 FILM NUMBER: 17508323 MAIL ADDRESS: STREET 1: C/O ARBUTUS BIOPHARMA CORP. STREET 2: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-01-03 0 0001290149 ProNAi Therapeutics Inc DNAI 0001628357 Kowalski Mark C/O PRONAI THERAPEUTICS, INC. 2150 885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 BRITISH COLUMBIA, CANADA 0 1 0 0 Chief Medical Officer Stock Option (right to buy Class A Common Stock) 1.54 2017-01-03 4 A 0 300000 0.00 A 2027-01-03 Common Stock 300000 300000 D The option vests as to 25% of the total shares on January 3, 2018, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on January 3, 2021, subject to the reporting person's provision of service to the issuer on each vesting date. /s/ Sukhi Jagpal as attorney-in-fact for Mark Kowalski, M.D., Ph.D. 2017-01-04